Exelixis
EXEL
#1777
Rank
A$16.89 B
Marketcap
A$62.76
Share price
0.53%
Change (1 day)
10.95%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company